CO-RO
Roche
cOmplete™ Protease Inhibitor Cocktail
Tablets provided in glass vials
Synonym(s):
protease inhibitor tablet
Sign Into View Organizational & Contract Pricing
All Photos(2)
About This Item
UNSPSC Code:
12352204
Recommended Products
form
tablet
packaging
vial of 20 tablets (11697498001)
vial of 3 × 20 tablets (11836145001)
manufacturer/tradename
Roche
optimum pH
<7.5
solubility
aqueous buffer: soluble
absorption
0.08 at 280 nm
storage temp.
2-8°C
General description
cOmplete Protease Inhibitor Tablets inhibit a broad spectrum of serine, cysteine, and metalloproteases, as well as calpains. Due to the optimized composition of the tablets, they show excellent inhibition effects, and are well suited for the protection of proteins isolated from animal tissues, plants, yeast, and bacteria. cOmplete tablets contain EDTA and both irreversible and reversible protease inhibitors.
Specificity
Mixture of several protease inhibitors with broad inhibitory specificity. For the inhibition of serine, cysteine, and metalloproteases in bacterial, mammalian, yeast, and plant cell extracts.
Application
cOmplete™ Protease Inhibitor Cocktail has been used as a component of
- lysis buffer for the homogenisation of rat cavernosal smooth muscle (CSM) for obtaining membranous and cytosolic fractions
- cold buffer A for preparing cytosolic and nuclear extracts
- lysis buffer for homogenisation of tissues for determining protein expression by western blot
- phosphate buffered saline (PBS) for the lysis of rat retinae for enzyme linked immunosorbent assay (ELISA)
cOmplete™ is used for the inhibition of serine, cysteine, and metalloproteases in bacterial, mammalian, yeast, and plant cell extracts.
cOmplete contains both reversible and irreversible protease inhibitors. Therefore, we recommend the addition of cOmplete to all stock buffers and solutions normally protected with protease inhibitors, and not just during the initial purification steps.
cOmplete contains EDTA (1 tablet yields a 1 mM EDTA solution in 50 ml). Therefore, the extraction buffer should not contain divalent cations like Ca2+ , Mg2+, or Mn2+, otherwise the inhibition of the metalloproteases might be incomplete. If the protein of interest will be purified by IMAC (Immobilized Metal Affinity Chromatography), for example, Poly-His-tagged recombinant proteins, EDTA has to be eliminated (e.g., by dialysis) prior to the chromatography.
Alternatively, the product cOmplete EDTA-free can be used. These tablets are identical to cOmplete, with the exception that no EDTA or other chelating agent is present.
cOmplete Tablets inhibit proteolytic activity in large extraction volumes (up to 50 ml). If you are working with smaller volumes (up to 10 ml), we recommend to use cOmplete, Mini. The composition of the cOmplete, Mini Tablet is identical to the normal cOmplete Tablet.
cOmplete contains both reversible and irreversible protease inhibitors. Therefore, we recommend the addition of cOmplete to all stock buffers and solutions normally protected with protease inhibitors, and not just during the initial purification steps.
cOmplete contains EDTA (1 tablet yields a 1 mM EDTA solution in 50 ml). Therefore, the extraction buffer should not contain divalent cations like Ca2+ , Mg2+, or Mn2+, otherwise the inhibition of the metalloproteases might be incomplete. If the protein of interest will be purified by IMAC (Immobilized Metal Affinity Chromatography), for example, Poly-His-tagged recombinant proteins, EDTA has to be eliminated (e.g., by dialysis) prior to the chromatography.
Alternatively, the product cOmplete EDTA-free can be used. These tablets are identical to cOmplete, with the exception that no EDTA or other chelating agent is present.
cOmplete Tablets inhibit proteolytic activity in large extraction volumes (up to 50 ml). If you are working with smaller volumes (up to 10 ml), we recommend to use cOmplete, Mini. The composition of the cOmplete, Mini Tablet is identical to the normal cOmplete Tablet.
Features and Benefits
Use cOmplete Protease Inhibitor Tablets to protect your proteins from a wide range of proteases. In just minutes, uninhibited proteolytic activity can degrade the protein you have spent days isolating. Each of these convenient water-soluble tablets contains a blend of protease inhibitors that inhibits proteolytic activity from most cell types, including animals, plants, yeast, and bacteria. No weighing or measuring is necessary, ensuring consistent results.
- Easy-to-use: Simply drop a quick-dissolving tablet into your buffer.
- Complete protection: Instantly protect your proteins against a broad range of proteases.
- Flexible: Protect proteins in extracts from almost any tissue or cell, including animals, plants, yeast, bacteria, or fungi.
- Safe: Choose non-toxic inhibitors that pose no risk to you or those around you.
- Suitable for IMAC purification: Purify poly-histidine tagged proteins with cOmplete His-Tag Purification Resin.
Components
Proprietary mixture of several protease inhibitors with broad inhibitory specificity.
Quality
Performance-tested with pancreas extract.
Physical form
Tablets in glass vials
Preparation Note
Working concentration: 1 tablet per 50 ml extraction solution
Working solution: Preparation of Working Solution:
One cOmplete Protease Inhibitor Tablet is sufficient for the inhibition of the proteolytic activity in 50 ml extraction solution. If very high proteolytic activity is present, one tablet should be used for 25 ml extraction buffer. Tablets can be added directly to the extraction medium. Alternatively, a stock solution (25 X conc.) can be prepared.
Preparation of Stock solution (25 X conc.):
Dissolve one cOmplete Protease Inhibitor tablet in 2 ml dist. water or in 2 ml 100 mM phosphate buffer, pH 7.0. The stock solution can also be prepared in 10 mM Tris buffer, pH 7.2 to 7.5.
Storage conditions (working solution): The stock solution can be stored at 2 to 8 °C for 1 to 2 weeks, or at least 12 weeks at -15 to -25 °C.
Working solution: Preparation of Working Solution:
One cOmplete Protease Inhibitor Tablet is sufficient for the inhibition of the proteolytic activity in 50 ml extraction solution. If very high proteolytic activity is present, one tablet should be used for 25 ml extraction buffer. Tablets can be added directly to the extraction medium. Alternatively, a stock solution (25 X conc.) can be prepared.
Preparation of Stock solution (25 X conc.):
Dissolve one cOmplete Protease Inhibitor tablet in 2 ml dist. water or in 2 ml 100 mM phosphate buffer, pH 7.0. The stock solution can also be prepared in 10 mM Tris buffer, pH 7.2 to 7.5.
Storage conditions (working solution): The stock solution can be stored at 2 to 8 °C for 1 to 2 weeks, or at least 12 weeks at -15 to -25 °C.
Reconstitution
Soluble in aqueous buffers, or add directly to extraction media. Alternatively, prepare 25x stock solutions in 2 ml water or 100 mM phosphate buffer, pH 7.0. Stock solution is stable for 1 to 2 weeks at 2 to 8 °C or at least 12 weeks at -15 to -25 °C; can also be used in thiol-containing solutions at 15 to 25 °C.
Other Notes
Inhibition efficiency is quickly and sensitively tested with the Universal Protease Substrate. For life science research only. Not for use in diagnostic procedures.
Legal Information
cOmplete is a trademark of Roche
Signal Word
Danger
Hazard Statements
Hazard Classifications
Eye Dam. 1 - Skin Corr. 1B
Storage Class Code
8A - Combustible, corrosive hazardous materials
WGK
WGK 2
Flash Point(F)
does not flash
Flash Point(C)
does not flash
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Christian Bressy et al.
PloS one, 17(12), e0276905-e0276905 (2022-12-16)
c-Rel, a member of the nuclear factor kappa B (NF-κB) family, is preferentially expressed by immune cells and is known to regulate inflammation, autoimmune diseases and cancer. However, there is a lack of therapeutic intervention to specifically inhibit c-Rel in
Chengfeng Xiao et al.
Developmental neurobiology, 67(4), 438-455 (2007-04-20)
Heat shock preconditioning can enhance locomotor and synaptic performance during subsequent hyperthermia. The molecular basis underlying this neural phenotypic modification is largely unknown. Here we report that directing the expression of the 70 kDa heat shock protein (HSP70) to motoneurons
Ethanol-induced erectile dysfunction and increased expression of pro-inflammatory proteins in the rat cavernosal smooth muscle are mediated by NADPH oxidase-derived reactive oxygen species
Leite LN, et al.
European Journal of Pharmacology, 804, 82-93 (2017)
Modulation of alpha-adrenoceptor signalling protects photoreceptors after retinal detachment by inhibiting oxidative stress and inflammation
Li T, et al.
British Journal of Pharmacology, 176(6), 801-813 (2019)
Macarena Tejos-Bravo et al.
Neurobiology of stress, 14, 100306-100306 (2021-03-06)
Sex differences in the brain have prompted many researchers to investigate the underlying molecular actors, such as the glucocorticoid receptor (GR). This nuclear receptor controls gene expression, including microRNAs (miRNAs), in non-neuronal cells. Here, we investigated sex-biased effects of GR
Articles
Get maximum protection after protein isolation by using protease and phosphatase inhibitor cocktail tablets from Roche.
Protocols
It is possible dissolve 1 tablet in as little as 2 ml double distilled Water, results in a 25x stock solution, without difficulty.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service